跳至主要内容
临床试验/NCT07558564
NCT07558564招募中不适用

Multicenter Real-World Evidence (RWE) Study: Evaluation of Platelet-Rich Plasma (PRP) Treatment in Tendinopathies

ReSport Clinic5 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2026年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
2,000
试验地点
5
主要终点
Visual Analog Scale

研究概览

简要总结

This multicenter, prospective, observational study, based on real-world evidence (RWE), aims to evaluate the efficacy and safety of Platelet-Rich Plasma (PRP) treatment across four types of tendinopathies: patellar, Achilles, epicondylar, and plantar fasciosis. Data collection and analysis will be conducted using the BioSmartData® platform, including hematology analyzers for PRP characterization, clinical variables, treatment protocols, and longitudinal assessment of therapeutic response.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical and/or ultrasound diagnosis of chronic tendinopathy (duration >6 weeks)
  • Age >18 years
  • Provision of written informed consent
  • Willingness and ability to complete follow-up assessments for 12 months

排除标准

  • Surgical treatment of the affected tendon within the previous 6 months
  • Corticosteroid injection within the last month
  • Systemic inflammatory disease (e.g., rheumatoid arthritis)
  • Coagulopathies or ongoing anticoagulant therapy
  • Complete blood count showing a platelet concentration <100 × 10⁹/L (to exclude patients with potential thrombocytopenia)
  • Pregnancy or breastfeeding

研究组 & 干预措施

Patellar tendinopathy

Patellar tendinopathy treated with PRP

干预措施: Platelet rich plasma (PRP) (Biological)

Achilles tendinopathy

Achilles tendinopathy treated with PRP

干预措施: Platelet rich plasma (PRP) (Biological)

Plantar fasciosis

Plantar fasciosis treated with PRP

干预措施: Platelet rich plasma (PRP) (Biological)

Chronic epycondylitis

Chronic epycondylitis treated with PRP

干预措施: Platelet rich plasma (PRP) (Biological)

结局指标

主要结局

Visual Analog Scale

时间窗: From baseline up to 12 months post-treatment

VISA-P

时间窗: baseline, 1 month, 3 months, 6 months and 12 months

Change in pain and functional limitation assessed using the Victorian Institute of Sport Assessment-Patella (VISA-P) questionnaire. Scores range from 0 to 100, with higher scores indicating better function and lower pain levels.

VISA-A

时间窗: baseline, 1 month, 3 months, 6 months and 12 months

The VISA-A is an eight item questionnaire measures Achilles tendon pain and function, with scores ranging from 0 to 100 (higher scores indicating better function).

Patient Rated Tennis Elbow Evaluation Scale

时间窗: baseline, 1 month, 3 months, 6 months and 12 months

The Patient-Rated Tennis Elbow Evaluation (PRTEE) is a 15-item self-report questionnaire designed to measure pain and functional disability in patients with lateral epicondylitis (tennis elbow). It includes a 5-item pain subscale and a 10-item function subscale, providing a total score out of 100 to assess, evaluate, and monitor recovery.

Foot Function Index

时间窗: baseline, 1 month, 3 months, 6 months and 12 months

The Foot Function Index (FFI) is a 23-item, self-administered questionnaire designed to measure the impact of foot pathology on function, assessing pain, disability, and activity limitation. It uses a 0-10 Likert scale for items within three subscales, with higher total percentages (0-100%) indicating greater, more severe pain and dysfunction.

次要结局

  • Adverse events(1 month, 3 months, 6 months, 12 months)
  • Predictive factors of response to PRP treatment(baseline)

研究者

发起方
ReSport Clinic
申办方类型
Other
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验